Allogene Therapeutics, Inc. short interest in 2024
In 2024, Allogene Therapeutics, Inc.'s disclosed short interest ran from 17.95% of shares outstanding on 12 Jan 2024 to 14.74% on 31 Dec 2024, a change of -3.21 percentage points. The year's high was 25.59% on 14 Jun 2024 and its low 13.72% on 31 Jan 2024, averaging 18.74% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 23.06 days on 15 Oct 2024. Full history: Allogene Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 17.95% (12 Jan 2024)
- End of year
- 14.74% (31 Dec 2024)
- Change
- -3.21 pp
- High
- 25.59% (14 Jun 2024)
- Low
- 13.72% (31 Jan 2024)
- Average
- 18.74%
- Highest days to cover
- 23.06 (15 Oct 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 17.95% | 7.19 | |
| 31 Jan 2024 | 13.72% | 9.27 | |
| 15 Feb 2024 | 13.93% | 9.13 | |
| 29 Feb 2024 | 14.86% | 12.20 | |
| 15 Mar 2024 | 16.41% | 8.32 | 10-K filed, results (8-K) |
| 28 Mar 2024 | 18.11% | 16.63 | |
| 15 Apr 2024 | 18.55% | 19.21 | |
| 30 Apr 2024 | 20.03% | 16.48 | |
| 15 May 2024 | 21.54% | 16.81 | 10-Q filed, results (8-K) |
| 31 May 2024 | 23.99% | 12.65 | |
| 14 Jun 2024 | 25.59% | 16.68 | |
| 28 Jun 2024 | 24.47% | 9.68 | |
| 15 Jul 2024 | 25.56% | 18.14 | |
| 31 Jul 2024 | 22.33% | 13.69 | |
| 15 Aug 2024 | 18.76% | 22.26 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 18.62% | 22.96 | |
| 13 Sep 2024 | 18.74% | 22.48 | |
| 30 Sep 2024 | 18.42% | 17.74 | |
| 15 Oct 2024 | 18.80% | 23.06 | |
| 31 Oct 2024 | 17.71% | 18.96 | |
| 15 Nov 2024 | 16.72% | 12.87 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 14.87% | 11.53 | |
| 13 Dec 2024 | 15.44% | 13.86 | |
| 31 Dec 2024 | 14.74% | 10.69 |
See also: Allogene Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.